In order to investigate whether government regulations against corruption can affect the economic growth of a country, we analyze the dependence between Gross Domestic Product (GDP) per capita growth rates and changes in the Corruption Perceptions Index (CPI). For the period 1999-2004 on average for all countries in the world, we find that an increase of CPI by one unit leads to an increase of ...

This paper examines convergence of real GDP per capita in the selected East Asian countries and this relationship with selected Middle East countries during the period 1950-2009. The reason behind this refers to the fact that East Asia countries (including China, Hong Kong, Singapore, Malaysia, Indonesia, Thailand, Japan and South Korea) have been involved in achieving success arising from regi...

Increasingly the governments are facing pressures to increase budgetary allocations to social sectors. Recently there has been suggestion to increase the government budget allocations to health sector and increase it to 3 per cent of GDP. Is this feasible goal and in what time-frame? Health being State subject in India and much depends on the ability of the State governments to allocate higher ...

Abstract Since colonial times, substantial regional income disparities have been reported for Indonesia. However, in spite of a wide variety available data and indicators, so far published on Indonesian per capita GDP times are limited to macro-estimates the entire archipelago or confined either Java Outer Islands. In this paper we provide first attempt arrive at estimates diverging living stan...

Despite the enormous economic benefit from accession to the WTO, overall welfare of trade liberalization might be compromised since pollution from production also increased. Using plausibly exogeneous tariff reduction on Chinese goods caused by the WTO accession, variation in industry composition across cities, and variation in pollution intensity across industries, I study the effect of trade ...

OBJECTIVES This study aims to examine the impact of external price referencing (EPR) on on-patent medicine prices, adjusting for other factors that may affect price levels such as sales volume, exchange rates, gross domestic product (GDP) per capita, total pharmaceutical expenditure (TPE), and size of the pharmaceutical industry. METHODS Price data of 14 on-patent products, in 14 European cou...